SCHEMBL3188296

SCHEMBL3188296

Cc1cccc(NC(=O)NC2CCC(OCc3c(F)cccc3F)CC2)c1

nearest known ligand 0.72

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 8/20 0.72
▸ NPC1 O15118 5/20 0.59
▸ RAB9A P51151 5/20 0.59
▸ DCUN1D1 Q96GG9 3/20 0.52
▸ UBE2M P61081 2/20 0.48
▸ MEN1 O00255 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ GAA P10253 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ ALDH1A1 P00352 2/20 0.46
▸ ALPL P05186 1/20 0.45
▸ ALPI P09923 1/20 0.45
▸ ALPG P10696 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3188291 1.00 EPHX2 (0.72) EPHX2NPC1RAB9ADCUN1D1UBE2M
SCHEMBL3183175 0.89 EPHX2 (0.66) EPHX2NPC1RAB9AMEN1KMT2A
SCHEMBL3183168 0.89 EPHX2 (0.66) EPHX2NPC1RAB9AMEN1KMT2A
SCHEMBL3182153 0.89 EPHX2 (0.74) EPHX2NPC1RAB9ADCUN1D1UBE2M
SCHEMBL3182145 0.89 EPHX2 (0.74) EPHX2NPC1RAB9ADCUN1D1UBE2M
SCHEMBL3178477 0.88 EPHX2 (0.72) EPHX2NPC1RAB9AMEN1KMT2A
SCHEMBL3178470 0.88 EPHX2 (0.72) EPHX2NPC1RAB9AMEN1KMT2A
SCHEMBL3190106 0.88 EPHX2 (0.69) EPHX2NPC1RAB9AMEN1KMT2A
SCHEMBL12932322 0.88 EPHX2 (0.69) EPHX2NPC1RAB9AMEN1KMT2A
SCHEMBL3181043 0.87 EPHX2 (0.72) EPHX2NPC1RAB9ADCUN1D1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7662910-B2 Inhibitors for the soluble epoxide hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-02-16 — — US claimed
US-8476043-B2 Inhibitors for the soluble epoxide hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-07-02 — — US disclosed
US-8476043-B2 Inhibitors for the soluble epoxide hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-07-02 — — US disclosed
US-20110021448-A1 Inhibitors for the Soluble Epoxide Hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-01-27 — — US disclosed
US-20110021448-A1 Inhibitors for the Soluble Epoxide Hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-01-27 — — US disclosed
US-7662910-B2 Inhibitors for the soluble epoxide hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-02-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021448-A1 Inhibitors for the Soluble Epoxide Hydrolase EPHX1, EPHX2, NCEH1 EPHX2 2/4885NPC1 778/4885RAB9A 3525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback